Armata Pharmaceuticals
ARMP
16 hedge funds and large institutions have $9.19M invested in Armata Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$7.57M |
| 2 |
BC
Broadfin Capital
New York
|
+$3.6M |
| 3 |
MP
MSD Partners
New York
|
+$1.79M |
| 4 |
AC
Armistice Capital
New York
|
+$612K |
| 5 |
PA
Perceptive Advisors
New York
|
+$522K |
Top Sellers
ARMP Hedge Fund Activity: Q3 2015 in Review
16 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q3 2015, worth a combined $9.19M.
Buyers outnumbered sellers: 16 funds opened new ARMP positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Third Security, opening a new position worth an estimated $7.57M.
- 16 institutional investors held Armata Pharmaceuticals (ARMP) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $9.19M of Armata Pharmaceuticals stock for Q3 2015.
- 16 funds opened new Armata Pharmaceuticals positions in Q3 2015 and 0 closed out, a net change of +16 holders.
- The largest Armata Pharmaceuticals buyer in Q3 2015 was Third Security, an estimated $7.57M added.
Based on aggregated 13F filings for Q3 2015.